|
1
|
Laskin DL and Pendino KJ: Macrophages and
inflammatory mediators in tissue injury. Annu Rev Pharmacol
Toxicol. 35:655–677. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Blank V, Hirsch E, Challis JR, Romero R
and Lye SJ: Cytokine signaling, inflammation, innate immunity and
preterm labour - a workshop report. Placenta. 29(Suppl A):
S102–S104. 2008. View Article : Google Scholar
|
|
3
|
Weinberg JB, Misukonis MA, Shami PJ, et
al: Human mononuclear phagocyte inducible nitric oxide synthase
(iNOS): analysis of iNOS mRNA, iNOS protein, biopterin, and nitric
oxide production by blood monocytes and peritoneal macrophages.
Blood. 86:1184–1195. 1995.PubMed/NCBI
|
|
4
|
Ricciotti E and FitzGerald GA:
Prostaglandins and inflammation. Arterioscler Thromb Vasc Biol.
31:986–1000. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Grossman CJ, Wiseman J, Lucas FS,
Trevethick MA and Birch PJ: Inhibition of constitutive and
inducible cyclooxygenase activity in human platelets and
mononuclear cells by NSAIDs and Cox 2 inhibitors. Inflamm Res.
44:253–257. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
O’Neill GP, Kennedy BP, Mancini JA, et al:
Selective inhibitors of COX-2. Agents Actions Suppl. 46:159–168.
1995.
|
|
7
|
Pouliot M, Baillargeon J, Lee JC, Cleland
LG and James MJ: Inhibition of prostaglandin endoperoxide
synthase-2 expression in stimulated human monocytes by inhibitors
of p38 mitogen-activated protein kinase. J Immunol. 158:4930–4937.
1997.PubMed/NCBI
|
|
8
|
Zhang G and Ghosh S: Toll-like
receptor-mediated NF-kappaB activation: a phylogenetically
conserved paradigm in innate immunity. J Clin Invest. 107:13–19.
2001. View
Article : Google Scholar : PubMed/NCBI
|
|
9
|
Baeuerle PA and Baltimore D: I kappa B: a
specific inhibitor of the NF-kappa B transcription factor. Science.
242:540–546. 1988. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Baker JR Jr and Baldwin JL: Allergy and
immunology. JAMA. 275:1794–1795. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Ajizian SJ, English BK and Meals EA:
Specific inhibitors of p38 and extracellular signal-regulated
kinase mitogen-activated protein kinase pathways block inducible
nitric oxide synthase and tumor necrosis factor accumulation in
murine macrophages stimulated with lipopolysaccharide and
interferon-gamma. J Infect Dis. 179:939–944. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Riches DW, Chan ED, Zahradka EA, Winston
BW, Remigio LK and Lake FR: Cooperative signaling by tumor necrosis
factor receptors CD120a (p55) and CD120b (p75) in the expression of
nitric oxide and inducible nitric oxide synthase by mouse
macrophages. J Biol Chem. 273:22800–22806. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Singer CA, Baker KJ, McCaffrey A, AuCoin
DP, Dechert MA and Gerthoffer WT: p38 MAPK and NF-kappaB mediate
COX-2 expression in human airway myocytes. Am J Physiol Lung Cell
Mol Physiol. 285:L1087–L1098. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zheng X, Chang RL, Cui XX, Avila G, Huang
MT, Liu Y, Kong AN, Rabson AB and Conney AH: Inhibition of NF-κB by
(E)3-[(4-methylphenyl)-sulfonyl]-2-propenenitrile (BAY11-7082; BAY)
is associated with enhanced
12-O-tetradecanoylphorbol-13-acetate-induced growth suppression and
apoptosis in human prostate cancer PC-3 cells. Int J Oncol.
32:257–264. 2008.
|
|
15
|
Guha M and Mackman N: LPS induction of
gene expression in human monocytes. Cell Signal. 13:85–94. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Lawrence T, Willoughby DA and Gilroy DW:
Anti-inflammatory lipid mediators and insights into the resolution
of inflammation. Nat Rev Immunol. 2:787–795. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Mori N, Yamada Y, Ikeda S, et al: Bay
11-7082 inhibits transcription factor NF-kappaB and induces
apoptosis of HTLV-I-infected T-cell lines and primary adult T-cell
leukemia cells. Blood. 100:1828–1834. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Hsiao WL and Liu L: The role of
traditional Chinese herbal medicines in cancer therapy - from TCM
theory to mechanistic insights. Planta Med. 76:1118–1131. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Ma HD, Deng YR, Tian Z and Lian ZX:
Traditional Chinese medicine and immune regulation. Clin Rev
Allergy Immunol. 44:229–241. 2013. View Article : Google Scholar
|
|
20
|
Melillo B and Smith AB III: A unified
synthetic strategy to the cryptocarya family of natural products
exploiting anion relay chemistry (ARC). Org Lett. 15:2282–2285.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Porsti I and Paakkari I: Nitric
oxide-based possibilities for pharmacotherapy. Ann Med. 27:407–420.
1995. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Kubes P and McCafferty DM: Nitric oxide
and intestinal inflammation. Am J Med. 109:150–158. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Southan GJ and Szabo C: Selective
pharmacological inhibition of distinct nitric oxide synthase
isoforms. Biochem Pharmacol. 51:383–394. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Taniguchi T: Regulation of cytokine gene
expression. Annu Rev Immunol. 6:439–464. 1988. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Hughes TK, Kaspar TA and Coppenhaver DH:
Synergy of antiviral actions of TNF and IFN-gamma: evidence for a
major role of TNF-induced IFN-beta. Antiviral Res. 10:1–9. 1988.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Knott C, Stern G and Wilkin GP:
Inflammatory regulators in Parkinson’s disease: iNOS, lipocortin-1,
and cyclooxygenases-1 and -2. Mol Cell Neurosci. 16:724–739. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Golde S, Coles A, Lindquist JA and
Compston A: Decreased iNOS synthesis mediates dexamethasone-induced
protection of neurons from inflammatory injury in vitro. Eur J
Neurosci. 18:2527–2537. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Lee SH, Park SA, Ko SH, et al: Insulin
resistance and inflammation may have an additional role in the link
between cystatin C and cardiovascular disease in type 2 diabetes
mellitus patients. Metabolism. 59:241–246. 2010. View Article : Google Scholar
|
|
29
|
Fukata M and Abreu MT: Role of Toll-like
receptors in gastrointestinal malignancies. Oncogene. 27:234–243.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Giuliano F and Warner TD: Origins of
prostaglandin E2: involvements of cyclooxygenase (COX)-1
and COX-2 in human and rat systems. J Pharmacol Exp Ther.
303:1001–1006. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Park JW, Kwon OK, Jang HY, et al: A leaf
methanolic extract of Wercklea insignis attenuates the
lipopolysaccharide-induced inflammatory response by blocking the
NF-kappaB signaling pathway in RAW 264.7 macrophages. Inflammation.
35:321–331. 2012. View Article : Google Scholar
|
|
32
|
Connelly L, Palacios-Callender M, Ameixa
C, Moncada S and Hobbs AJ: Biphasic regulation of NF-kappa B
activity underlies the pro- and anti-inflammatory actions of nitric
oxide. J Immunol. 166:3873–3881. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Viatour P, Merville MP, Bours V and
Chariot A: Phosphorylation of NF-kappaB and IkappaB proteins:
implications in cancer and inflammation. Trends Biochem Sci.
30:43–52. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Bylund J, MacDonald KL, Brown KL, et al:
Enhanced inflammatory responses of chronic granulomatous disease
leukocytes involve ROS-independent activation of NF-kappa B. Eur J
Immunol. 37:1087–1096. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Zhang YL and Dong C: MAP kinases in immune
responses. Cell Mol Immunol. 2:20–27. 2005.PubMed/NCBI
|
|
36
|
Lee HS, Ryu DS, Lee GS and Lee DS:
Anti-inflammatory effects of dichloromethane fraction from
Orostachys japonicus in RAW 264.7 cells: suppression of NF-kappaB
activation and MAPK signaling. J Ethnopharmacol. 140:271–276. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Hayden MS and Ghosh S: Signaling to
NF-kappaB. Genes Dev. 18:2195–2224. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Sakurai H, Chiba H, Miyoshi H, Sugita T
and Toriumi W: IkappaB kinases phosphorylate NF-kappaB p65 subunit
on serine 536 in the transactivation domain. J Biol Chem.
274:30353–30356. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Kuprash DV, Udalova IA, Turetskaya RL,
Rice NR and Nedospasov SA: Conserved kappa B element located
downstream of the tumor necrosis factor alpha gene: distinct
NF-kappa B binding pattern and enhancer activity in LPS activated
murine macrophages. Oncogene. 11:97–106. 1995.PubMed/NCBI
|
